016580.KS
Whan In Pharm Co.,Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 10,480.00
+3.35%Margins
Gross margin
37.1%
EBITDA margin
12.0%
EBIT margin
9.4%
Net margin
8.5%
FCF margin
2.2%
—
Return on equity
—
Return on assets
—
Return on invested capital
—
Asset turnover
KRW 9.0B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026